Cardiology and cardiovascular disease Archives - Page 11 of 13

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment

Sarah L Anderson PharmD, Joel C Marrs PharmD

Article Type

Review

Published

08 Aug 2018

This review examines sacubitril/valsartan, which has demonstrated safety and efficacy when it comes to blood pressure lowering, making it a promising antihypertensive agent.

Adding ezetimibe to statin therapy: latest evidence and clinical implications

Marija Vavlukis MD, PhD, FESC, Ana Vavlukis MSc

Article Type

Review

Published

09 Jul 2018

This review examines the therapeutic efficacy and safety of ezetimibe in combination therapy with statins and its potential side effects.

Combination therapy in the treatment of hypertension

Carolina Guerrero-García MD, Alberto Francisco Rubio-Guerra PhD

Article Type

Review

Published

06 Jun 2018

This article reviews the latest information available regarding the treatment of hypertension with combination therapy.

Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil

Edgardo Kaplinsky MD, Gordon Mallarkey PhD

Article Type

Review

Published

23 Apr 2018

This article examines omecamtiv mecarbil, which is a first-in-class cardiac myosin activator used in the treatment of heart failure.

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease

Constantine E Kosmas MD, PhD, Ian Martinez MD, Andreas Sourlas, Kyriaki V Bouza MD, Frederick N Campos MD, Verenisse Torres MD, Peter D Montan MD, Eliscer Guzman MD

Article Type

Review

Published

28 Mar 2018

This review aims to present and discuss the current clinical and scientific evidence pertaining to the significance of HDL functionality over the actual HDL-C concentration in mediating the favorable effects on the cardiovascular system.